NVO CIK: 353278

Novo Nordisk A/S Sponsored ADR

  • Denmark
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions DKK
FY21:
85.6
FY22:
108
FY23:
140
FY24:
162
FY25:
172
(positive)
Change from FY21 to FY25
billions DKK
FY21:
109
FY22:
133
FY23:
175
FY24:
304
FY25:
370
Total assets
Change from FY21 to FY25
billions DKK
FY21:
195
FY22:
241
FY23:
314
FY24:
466
FY25:
543

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions DKK
FY21:
99.5
FY22:
121
FY23:
170
FY24:
218
FY25:
216
(negative)
Change from FY21 to FY25
billions DKK
FY21:
24.2
FY22:
36.8
FY23:
38.3
FY24:
105
FY25:
133
(positive)
Change from FY21 to FY25
billions DKK
FY21:
70.7
FY22:
83.5
FY23:
107
FY24:
143
FY25:
194
Total liabilities & equity
Change from FY21 to FY25
billions DKK
FY21:
195
FY22:
241
FY23:
314
FY24:
466
FY25:
543

All amounts in billions DKK Data source:SEC EDGAR